Side effects associated with estrogen-progestogen treatment
The summary of product characteristics for Tridestra (estradiol valerate, medroxyprogesterone acetate; Orion) now states that estrogen-progestogen treatment is associated with myocardial infarction, gall bladder disease, chloasma, erythema multiforme, pancreatitis and probable dementia over the age of 65 years. Hereditary angiodema has been added to the list of conditions that require supervision with Tridestra treatment.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069148
Recommended from Pharmaceutical Press